Abstract
One hundred patients were at random given an intravenous injection of equal amounts of either diatrizoate or iopromide. Subjective patient discomfort and objective parameters of adverse reactions were recorded. There were significantly fewer patients with adverse effects in the iopromide group, both as an overall estimate and especially for heat sensation, nausea and increase in heart rate. Iopromide is recommended for increased patient safety.
Get full access to this article
View all access options for this article.
References
1.
Andrew
E.
: Method for assessment of the reporting standard of clinical trials with roentgen contrast media . Acta Radiol. Diagnosis
25 (1984 ), 55 .
2.
Boijsen
E.
Aakhus
T.
(editors): Iohexol-Omnipaque. Clinical experience with a new non-ionic contrast medium . Acta Radiol. (1984 ) Suppl. No. 366 .
3.
Cochran
S. T.
Ballard
J. W.
Katzberg
R. W.
: Evaluation of iopamidol and diatrizoate in excretory urography . Amer. J. Roentgenol.
151 (1988 ), 523 .
4.
Lalli
A. F.
: Contrast media reactions. Death analysis and hypothesis . Radiology
134 (1980 ), 1 .
5.
Taenzer
V.
Zeitler
E.
(editors): Contrast media in urography, angiography and computerized tomography . Fortschr. Roentgenstr. (1983 ) Suppl. No. 118 .